These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 2809510)

  • 1. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.
    Fong Y; Tracey KJ; Moldawer LL; Hesse DG; Manogue KB; Kenney JS; Lee AT; Kuo GC; Allison AC; Lowry SF
    J Exp Med; 1989 Nov; 170(5):1627-33. PubMed ID: 2809510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.
    Tracey KJ; Fong Y; Hesse DG; Manogue KR; Lee AT; Kuo GC; Lowry SF; Cerami A
    Nature; 1987 Dec 17-23; 330(6149):662-4. PubMed ID: 3317066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.
    Fischer E; Marano MA; Van Zee KJ; Rock CS; Hawes AS; Thompson WA; DeForge L; Kenney JS; Remick DG; Bloedow DC
    J Clin Invest; 1992 May; 89(5):1551-7. PubMed ID: 1533231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic responses to cachectin/TNF. A brief review.
    Tracey KJ; Cerami A
    Ann N Y Acad Sci; 1990; 587():325-31. PubMed ID: 2193578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase.
    Jansen PM; Pixley RA; Brouwer M; de Jong IW; Chang AC; Hack CE; Taylor FB; Colman RW
    Blood; 1996 Mar; 87(6):2337-44. PubMed ID: 8630396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon-gamma.
    Jansen PM; van der Pouw Kraan TC; de Jong IW; van Mierlo G; Wijdenes J; Chang AA; Aarden LA; Taylor FB; Hack CE
    Blood; 1996 Jun; 87(12):5144-51. PubMed ID: 8652827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour necrosis factor (cachectin) and other cytokines in septic shock: a review of the literature.
    Dofferhoff AS; Vellenga E; Limburg PC; van Zanten A; Mulder PO; Weits J
    Neth J Med; 1991 Aug; 39(1-2):45-62. PubMed ID: 1961351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1, -6 and tumor necrosis factor-alpha release is down-regulated in whole blood from septic patients.
    Kremer JP; Jarrar D; Steckholzer U; Ertel W
    Acta Haematol; 1996; 95(3-4):268-73. PubMed ID: 8677754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cachectin: a hormone that triggers acute shock and chronic cachexia.
    Tracey KJ; Lowry SF; Cerami A
    J Infect Dis; 1988 Mar; 157(3):413-20. PubMed ID: 3278061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli.
    Creasey AA; Stevens P; Kenney J; Allison AC; Warren K; Catlett R; Hinshaw L; Taylor FB
    Circ Shock; 1991 Feb; 33(2):84-91. PubMed ID: 2049816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cachectin/TNF and other cytokines in sepsis.
    Zentella A; Manogue K; Cerami A
    Prog Clin Biol Res; 1991; 367():9-24. PubMed ID: 1924435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome.
    Casey LC; Balk RA; Bone RC
    Ann Intern Med; 1993 Oct; 119(8):771-8. PubMed ID: 8379598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice.
    Starnes HF; Pearce MK; Tewari A; Yim JH; Zou JC; Abrams JS
    J Immunol; 1990 Dec; 145(12):4185-91. PubMed ID: 2124237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody.
    Hinshaw LB; Emerson TE; Taylor FB; Chang AC; Duerr M; Peer GT; Flournoy DJ; White GL; Kosanke SD; Murray CK
    J Trauma; 1992 Oct; 33(4):568-73. PubMed ID: 1433404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEG-BP-30 monotherapy attenuates the cytokine-mediated inflammatory cascade in baboon Escherichia coli septic shock.
    Espat NJ; Cendan JC; Beierle EA; Auffenberg TA; Rosenberg J; Russell D; Kenney JS; Fischer E; Montegut W; Lowry SF
    J Surg Res; 1995 Jul; 59(1):153-8. PubMed ID: 7630120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two types of septic shock classified by the plasma levels of cytokines and endotoxin.
    Endo S; Inada K; Inoue Y; Kuwata Y; Suzuki M; Yamashita H; Hoshi S; Yoshida M
    Circ Shock; 1992 Dec; 38(4):264-74. PubMed ID: 1292890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced release of elastase is not concomitant with increased secretion of granulocyte-activating cytokines in whole blood from patients with sepsis.
    Ertel W; Jarrar D; Jochum M; Thiele V; Kenney J; Faist E; Schildberg FW
    Arch Surg; 1994 Jan; 129(1):90-7; discussion 97-8. PubMed ID: 8279945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis.
    Zisman DA; Kunkel SL; Strieter RM; Gauldie J; Tsai WC; Bramson J; Wilkowski JM; Bucknell KA; Standiford TJ
    Shock; 1997 Nov; 8(5):349-56. PubMed ID: 9361345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous modulators of TNF and IL-1 response are under partial control of TNF in baboon bacteremia.
    Redl H; Schlag G; Paul E; Bahrami S; Buurman WA; Strieter RM; Kunkel SL; Davies J; Foulkes R
    Am J Physiol; 1996 Nov; 271(5 Pt 2):R1193-8. PubMed ID: 8945953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.